Report cover image

Global Parkinson Disease Drug Competitive Landscape Professional Research Report 2024

Publisher DIResearch
Published Jun 10, 2024
Length 170 Pages
SKU # DIR18897303

Description

Global Parkinson Disease Drug Competitive Landscape Professional Research Report 2024



Research Summary

Parkinson＇s disease drugs are medications prescribed to individuals diagnosed with Parkinson＇s disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons in the brain. These drugs are primarily aimed at alleviating the motor symptoms of the condition, which include tremors, muscle rigidity, and bradykinesia (slowness of movement). The most commonly prescribed class of drugs for Parkinson＇s disease are levodopa medications, which are converted to dopamine in the brain to help replenish the deficient neurotransmitter. Other drug classes, such as dopamine agonists, MAO-B inhibitors, and COMT inhibitors, are also used to manage symptoms and extend the effectiveness of levodopa. While these drugs can provide significant relief from the motor symptoms, they do not cure Parkinson＇s disease, and their use may be tailored to each patient＇s specific needs and stage of the disease.

According to DIResearch's in-depth investigation and research, the global Parkinson Disease Drug market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Parkinson Disease Drug include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, Valeant, H.Lundbeck, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Parkinson Disease Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Parkinson Disease Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Parkinson Disease Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Parkinson Disease Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Parkinson Disease Drug Include:

Merck

Akorn

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

Valeant

H.Lundbeck

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Bausch Health

Parkinson Disease Drug Product Segment Include:

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Others

Parkinson Disease Drug Product Application Include:

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Parkinson Disease Drug Industry PESTEL Analysis

Chapter 3: Global Parkinson Disease Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global Parkinson Disease Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Parkinson Disease Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Parkinson Disease Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Parkinson Disease Drug Market Overview
1.1 Product Definition and Statistical Scope
1.2 Parkinson Disease Drug Product by Type
1.2.1 Global Parkinson Disease Drug Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Others
1.3 Parkinson Disease Drug Product by Application
1.3.1 Global Parkinson Disease Drug Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson Disease Drug Market Revenue Analysis (2019-2030)
1.5 Parkinson Disease Drug Market Development Status and Trends
1.5.1 Parkinson Disease Drug Industry Development Status Analysis
1.5.2 Parkinson Disease Drug Industry Development Trends Analysis
2 Parkinson Disease Drug Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Parkinson Disease Drug Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Parkinson Disease Drug Market Analysis by Regions
4.1 Parkinson Disease Drug Overall Market: 2023 VS 2024 VS 2030
4.2 Global Parkinson Disease Drug Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Parkinson Disease Drug Revenue and Market Share by Region (2019-2024)
4.2.2 Global Parkinson Disease Drug Revenue Forecast by Region (2025-2030)
5 Global Parkinson Disease Drug Market Size by Type and Application
5.1 Global Parkinson Disease Drug Market Size by Type
5.2 Global Parkinson Disease Drug Market Size by Application
6 North America
6.1 North America Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Parkinson Disease Drug Market Size by Type
6.4 North America Parkinson Disease Drug Market Size by Application
6.5 North America Parkinson Disease Drug Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Parkinson Disease Drug Market Size by Type
7.4 Europe Parkinson Disease Drug Market Size by Application
7.5 Europe Parkinson Disease Drug Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Parkinson Disease Drug Market Size by Type
8.4 China Parkinson Disease Drug Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Parkinson Disease Drug Market Size by Type
9.4 APAC (excl. China) Parkinson Disease Drug Market Size by Application
9.5 APAC (excl. China) Parkinson Disease Drug Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Parkinson Disease Drug Market Size by Type
10.4 Latin America Parkinson Disease Drug Market Size by Application
10.5 Latin America Parkinson Disease Drug Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Parkinson Disease Drug Market Size by Type
11.4 Middle East & Africa Parkinson Disease Drug Market Size by Application
11.5 Middle East & Africa Parkinson Disease Drug Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Parkinson Disease Drug Market Revenue by Key Manufacturers (2020-2024)
12.2 Parkinson Disease Drug Competitive Landscape Analysis and Market Dynamic
12.2.1 Parkinson Disease Drug Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Merck
13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Merck Parkinson Disease Drug Product Portfolio
13.1.3 Merck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Akorn
13.2.1 Akorn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Akorn Parkinson Disease Drug Product Portfolio
13.2.3 Akorn Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 GSK
13.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 GSK Parkinson Disease Drug Product Portfolio
13.3.3 GSK Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Novartis
13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Novartis Parkinson Disease Drug Product Portfolio
13.4.3 Novartis Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Portfolio
13.5.3 Boehringer Ingelheim Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Portfolio
13.6.3 Teva Pharmaceutical Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 Abbvie
13.7.1 Abbvie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Abbvie Parkinson Disease Drug Product Portfolio
13.7.3 Abbvie Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Kyowa Hakko Kirin Pharma
13.8.1 Kyowa Hakko Kirin Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Portfolio
13.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 Astellas Pharma
13.9.1 Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Astellas Pharma Parkinson Disease Drug Product Portfolio
13.9.3 Astellas Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Desitin Arzneimittel
13.10.1 Desitin Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Portfolio
13.10.3 Desitin Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.11 Endo Pharmaceuticals
13.11.1 Endo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Portfolio
13.11.3 Endo Pharmaceuticals Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.12 F.Hoffmann-La Roche
13.12.1 F.Hoffmann-La Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Portfolio
13.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.13 Valeant
13.13.1 Valeant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Valeant Parkinson Disease Drug Product Portfolio
13.13.3 Valeant Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.14 H.Lundbeck
13.14.1 H.Lundbeck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 H.Lundbeck Parkinson Disease Drug Product Portfolio
13.14.3 H.Lundbeck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.15 Apokyn
13.15.1 Apokyn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 Apokyn Parkinson Disease Drug Product Portfolio
13.15.3 Apokyn Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.16 Orion
13.16.1 Orion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.16.2 Orion Parkinson Disease Drug Product Portfolio
13.16.3 Orion Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.17 Stada Arzneimittel
13.17.1 Stada Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.17.2 Stada Arzneimittel Parkinson Disease Drug Product Portfolio
13.17.3 Stada Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.18 US WorldMeds
13.18.1 US WorldMeds Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.18.2 US WorldMeds Parkinson Disease Drug Product Portfolio
13.18.3 US WorldMeds Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.19 Bausch Health
13.19.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.19.2 Bausch Health Parkinson Disease Drug Product Portfolio
13.19.3 Bausch Health Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Parkinson Disease Drug Industry Chain Analysis
14.2 Parkinson Disease Drug Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Parkinson Disease Drug Typical Downstream Customers
14.4 Parkinson Disease Drug Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us